Bill Snyder
-
H. pylori and anemia – new evidence
The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide. Read MoreSep 22, 2016
-
Study explores anti-viral potential of existing drugs
Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read MoreSep 15, 2016
-
William Kaelin Jr., member of VUMC Biomedical Science Advisory Board, wins Lasker Award
William G. Kaelin, Jr., M.D., professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of the Vanderbilt University Medical Center (VUMC) Biomedical Science Advisory Board, has been named a winner… Read MoreSep 15, 2016
-
Researchers eye potential schizophrenia ‘switch’
Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice. Read MoreSep 15, 2016
-
Study reveals new clues to cystic fibrosis ‘gender gap’
A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” Read MoreSep 15, 2016
-
Diversity’s crucial role in medical, graduate education explored
Diversity. Inclusion. Excellence. Innovation. You can’t have one without the others. Read MoreSep 15, 2016
-
Symposium explores using music to improve social skills, ease PTSD
The Science of Song symposium explored the use of music and singing to help people with developmental disabilities like autism improve their social skills, and others with post-traumatic stress disorder (PTSD) recover from the traumatic events they’ve experienced. Read MoreSep 15, 2016
-
Restore T cells to fight leukemia
Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read MoreSep 14, 2016
-
Investigators create ‘Trojan Horse’ to fight Ebola
A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. Read MoreSep 8, 2016
-
Simple Beginnings ceremony celebrates new doctoral students
Vanderbilt University welcomed 92 new doctoral students Sept. 2 during the seventh annual Simple Beginnings ceremony in a Light Hall lecture room packed with family members and other well wishers. Read MoreSep 8, 2016
-
Lecture to focus on diversity in medical education
The importance of diversity and inclusion to medical and graduate education and research will be discussed on Sept. 8 during the first Flexner Discovery Lecture of the 2016-2017 academic year. Read MoreSep 1, 2016
-
Study suggests new way to treat rare autism disorder
A protein that plays a powerful role in learning and memory may be a key to improving treatment of a rare autism spectrum disorder called Pitt-Hopkins syndrome (PTHS), a new study suggests. Read MoreAug 25, 2016
-
Meeting jump-starts VUMC Strategy Framework process
A broad and diverse group of 150 Medical Center and University leaders, students, and community stakeholders met Monday afternoon at the Vanderbilt Student Life Center to advance Vanderbilt University Medical Center’s Strategy Framework process. Read MoreAug 18, 2016
-
New center will examine addiction at molecular level, develop treatments
Vanderbilt University researchers from diverse scientific disciplines are joining forces to help crack the stubborn mysteries of addiction through the new Vanderbilt Center for Addiction Research. Read MoreAug 17, 2016
-
Foundation’s support speeds search for new schizophrenia drugs at Vanderbilt
Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation. Read MoreAug 15, 2016
-
NIH grant bolsters mass spectrometry research initiatives
The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National Research Resource for Imaging Mass Spectrometry at Vanderbilt University School of Medicine. Read MoreAug 11, 2016
-
Team explores transcription factor’s autoimmunity role
Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at Vanderbilt University Medical Center reported recently. Read MoreAug 11, 2016
-
Research team takes aim at Ebola virus ‘decoy protein’
Using an antibody generated at Vanderbilt University Medical Center that neutralizes the Ebola virus, researchers at the Scripps Research Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read MoreAug 11, 2016
-
Assembly highlights value of VUMC’s people, culture
With the theme of “It’s About People,” Jeff Balser M.D., Ph.D., President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine, began the Summer Clinical Enterprise Leadership Assembly by urging nearly 1,000 Medical Center leaders in attendance in Langford Auditorium to consider the emotional needs of members of their teams. In particular, he asked leaders to recognize the psychological impact of recent tragic events happening across the U.S. and in other nations. Read MoreAug 11, 2016
-
Study explores low oxygen’s impact on antibody quality
Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. Read MoreAug 11, 2016